MTOR and cancer: Several research studies have highlighted the dysregulation of the mTOR pathway in other diseases like cancer and diabetes (Hsieh and Edlind, 2014) (Habib and Liang, 2014), cardiovascular disease (Chong et al., 2011; Yang and Ming, 2012), aging (Gharibi et al., 2014; Yang et al., 2014), neurodegenerative diseases (Jiang et al., 2013; Sarkar, 2013) as well as obesity (Martínez-Martínez et al., 2014).